Pure Global
NCT06394466

Thyroid Function and Autoimmunity in Subfertility Women and Assisted Reproductive Therapy

Evaluation of Thyroid Function and Autoimmunity in Subfertility Women and Thyroid Hormone Levels in the First Trimester of Assisted Reproduction
Rio de Janeiro State University·ClinicalTrials.gov·otherCompleted
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Ovarian Failure,Thyroid Diseases
Drug/Device/Intervention
Non Applicable
Study type
Observational
Intervention type
other
Sponsor & location
Primary sponsor
Rio de Janeiro State University
Location
RIo de Janeiro, Brazil
Timeline & enrollment
Phase
N/A
Start date
Jul 01, 2021
End date
Jul 31, 2023
Enrollment
453 participants
Primary outcome

TSH levels during assisted reproductive therapy and first trimester

Summary

The assessment of ovarian reserve is well established based on the dosage of anti-Mullerian
 hormone (AMH). The clinical applicability of detecting thyroid autoantibodies levels has been
 discussed as a potential marker of low-grade inflammation. There are no studies about the
 detection of these autoantibodies in infertile women. Our objective is to evaluate the
 association between ovarian reserve and thyroid function and its autoimmunity in infertile
 women seeking for assisted reproductive treatment (ART).Evaluation ot thyroid function in the
 first trimester in also be evaluated in women submitted to ART.

ICD-10 classifications
Postprocedural ovarian failureOvarian dysfunctionPrimary ovarian failureOvarian dysfunction, unspecifiedOther ovarian dysfunction
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06394466
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06394466 through Pure Global AI's free database. This phase not specified trial is sponsored by Rio de Janeiro State University and is currently Completed. The study focuses on Ovarian Failure,Thyroid Diseases. Target enrollment is 453 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.